• Hepamap defines the links between the liver and other disease areas; metabolic and cardiovascular disease, and cancer.
  • Hepamap identifies the risk factors liver disease; obesity, alcohol.
  • Hepamap provides support to H2020 in achieving its health research goals and objectives.
  • Hepamap contributes to increased awareness of liver disease.
  • Hepamap highlights the need for further liver research funding.

The HEPAMAP is an advocacy tool:

(1) for European hepatologists to highlight the further research needed with a view to influencing the EU research agenda and also;

(2) to raise awareness more generally of liver disease and its links with lifestyle factors such as obesity and alcohol, as well as with metabolic and cardiovascular disease and cancer.

You are invited to join EASL on December 10, 2014 at the European Parliament, Brussels, Belgium, for the launch of the research roadmap for liver disease.

Click here for more HEPAMAP information.

SAVE THE DATE! and join the conversation on Twitter